ISOO 2022: Educational Session Highlighting Retrospective Study of Belzupacap Sarotalocan versus Radiotherapy in Choroidal Melanoma »
Topline Data from a Retrospective, Matched Case Study Evaluating Belzupacap Sarotalocan (AU-011) versus Plaque Radiotherapy, Supports the Value of a Vision Preserving Therapy for the ...
ISOO 2022: Dr. Kim Presents Phase 2 SC AU-011 Data »
A Phase 2 Trial of belzupacap sarotalocan (AU-011), a First-in-class Targeted Therapy for Choroidal Melanoma via Suprachoroidal (SC) Administration
ISOO 2022: Dr. Shields Presents Phase 1b/2 IVT AU-011 Data »
A Phase 1b/2 Trial of belzupacap sarotalocan (AU-011), a First-in-Class Targeted Therapy for the Treatment of Choroidal Melanoma via Intravitreal Administration
ARVO 2022: Aura Preclinical Data Presented »
A First in Class Virus-Like Drug Conjugate (VDC) Shows Anti-tumor Activity in Cancers that Commonly Metastasize to the Choroid
AACR 2022: Aura Preclinical Data Presented »
Biological assessment of the virus-like drug conjugate AU-011 to specifically target a breadth of human cancer types
ASCO GU 2022: Aura Preclinical Data Presented »
Targeting urothelial neoplasia using an investigational virus-like drug conjugate
AAO 2021: Dr. Shields Presents Phase 1b/2 IVT AU-011 Data »
A Phase 1b/2 Trial of AU-011, an Investigational, Virus-Like Drug Conjugate (VDC) for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma (IL/CM) using ...
AAO 2021: Dr. Demirci Presents Phase 2 SC AU-011 Data »
A Phase 2 Trial of AU-011, an Investigational, Virus-Like Drug Conjugate (VDC) for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma (IL/CM) using ...
ASRS 2021: Dr. Mruthyunjaya Presents Phase 2 AU-011 Data »
A Phase 2 Trial of AU-011, an Investigational, Virus-Like Drug Conjugate (VDC) for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma (IL/CM) using ...
Euretina 2021: Aura Clinical Data Presented »
A Phase 2 Trial of AU-011for the Treatment of Primary Indeterminate Lesions and Small Choroidal Melanoma using Suprachoroidal Administration
ARVO 2021: Aura Clinical Data Presented »
Development of AU-011 for Choroidal Metastasis
ARVO 2021: Aura Preclinical Data Presented »
Ocular Distribution and Exposure of AU-011 After Suprachoroidal or Intravitreal Administration in an Orthotopic Rabbit Model of Human Uveal Melanoma
AAO 2020: Dr. Carol Shields Presents Overview of AU-011 »
AU-011, a Targeted Therapy for Primary Treatment of Choroidal Melanoma (CM) via Intravitreal (IVT) or Suprachoroidal (SC) Administration
ARVO 2020: Aura Preclinical Data Presented »
Ocular Distribution and Efficacy After Suprachoroidal Injection of AU-011 for Treatment of Ocular Melanoma” – Presented at AVRO 2020
ARVO 2020: Aura Phase 1b/2 Results Presented »
An Ongoing Phase 1B/2 Open-Label Clinical Trial to Evaluate the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma – Study Update” – Presented at ARVO 2020